Human bone marrow stromal cells repond to stimulation by the monokines IL-1 and TNF by producing colony-stimulating factors such as GM-CSF and G-CSF. In this study we show that I L -l a and TNFa act synergistically to stimulate GM-CSF and G-CSF production by cultured marrow stromal cells. We further show that I L -l a and TNFa synergistically stimulate production of GM-CSF and G-CSF by a clonal stroma-derived cell strain. Although IL-1 and TNF share many of the same biological activities, we show that I L -l a and TNFa have an unequal ability to induce myeloid-CSF production by both cultures, with I L -l a being the more potent inducer. We found that induction by I L -l a and TNFa was independent of cell proliferation. The effect of I L -l a and TNFa on production of the two myeloidCSFs by the clonal cells was significantly greater than the unfractionated passaged strornal cultures, having the greater effect on G-CSF production. The clonally derived stromal cells constitutively produced colony-stimulating activity, in particular GM-CSF, at levels easily detected by ELISA. These findings show that, in addition to the overlapping and additive activities of IL-la and TNFa, they can interact synergistically. Our findings further suggest that a small subpopulation of stroma cells may be the major producer of G-CSF in the marrow microenvironment during immune response. o 1994 ~i l e y -~i s s , Inc.
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Development of blood cells in the marrow occurs in close association with marrow mesenchymal cells termed bone marrow stromal cells. The marrow stroma is a complex tissue that is made up of many different cell types that include fibroblasts, adipocytes, endothelial cells, and macrophages (Dorshkind, 1990) . Stromal cell-derived cytokines are a major component in the pathways that regulate blood cell survival, proliferation, and differentiation (Singer and Keating, 1983; Gualtieri et al., 1984; Heard et al., 1982; Shadduck et al., 1983; Tsai et al., 1986; Zucali et al., 1987; Yang et al., 1988) . Uninduced cultured stromal cells release little, if any, detectable hematopoietic growth factors (HGFs) into the culture supernatant (Kittler et al., 1992; Guba et al., 1992) . However, when stimulated with the inflammatory mediators interleukin-1-alpha (IL-la) or tumor necrosis factor-alpha (TNFa), increased levels of soluble HGFs are found in stromal cultures supernatants.
Although IL-1 and TNF are unrelated in their amino acid sequences and known t o recognize different receptors (Aggarwal et al., 1985; Beutler and Cerami, 1985; Matsushima et al., 19861 , they display many of the same biological activities (Dinarello, 1989; Vassalli, 1992; Le and Vilcek, 1987) . One possible consequence of this apparent evolutionary convergence is that stimu-
lation with IL-1 versus TNF could theoretically result in subtle distinct physiologic responses. However, in many cases both TNF and IL-1 appear to be triggered by a common afferent signal. A second interesting possibility is that IL-1 and TNF actually work synergistically on at least some of their target cells. This molecular scenario would result in a significant expansion of the range of physiologic responses only at the cells which were targets for this synergy.
We therefore asked whether TNFa and IL-la might induce bone marrow stromal cells to secrete either granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), or both in a supra-additive or synergistic fashion. We now report that interleukin-la and TNFa interact synergistically to stimulate production of GM-CSF and G-CSF by cultured human bone marrow stromal cells. When co-stimulated with IL-la and TNFa, stroma cultures produce supra-additive levels of GM-and G-CSF compared to levels induced by either cytokine alone. In addition, we have found that IL-la and TNFa interact synergistically to stimulate GM-CSF and G-CSF production by a human marrow stroma-derived cell strain. These data indicate that IL-la and TNFa interact synergistically to stimulate HGF production by marrow stromal cells, and thereby identify a novel mechanism for amplification of the inflammatory response by combining afferent limb monokines.
MATERIALS AND METHODS
Cells Normal human bone marrow was obtained by aspiration from healthy adult volunteers, after informed consent, under a protocol approved by the University of Michigan Institutional Review Board.
Bone marrow stromal cell cultures
Bone marrow stromal (BMS) cell cultures were established from liquid cultures of mononuclear cells isolated by centrifugation over Ficoll-Hypaque (density 1.077 g/mL; Pharmacia, Piscataway, NJ) and the stroma1 cells separated by adherence to tissue culture plastic. The cells were grown to confluence in Iscove's modified Dulbecco's medium (Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (Hyclone Laboratories, Lo an, UT), 10% horse serum (Hyclone, St. Louis, MO), 1% Pen/Strep (Sigma Chemicals, St. Louis, MO), with 50% fresh medium exchange twice weekly, removing nonadherent cells with each exchange. Cultures were maintained at 37°C in a humidified environment with 5% CO,. Only early passaged (two to eight passages) BMS cells were used in the experiments described in this study. Experimental cultures were seeded at low density (1 x lo4 cells/mL) in six-well tissue culture plates (Costar, Cambridge, MA) and grown to visual confluence before initiation of experimental conditions.
Colony-derived stromal cell strains
The stroma-derived cell strains (CDCL) used in this study were generously provided by Jack Singer (VA Medical Center, Seattle, WA) . CDCL cultures were established as previously described (Singer, 1989) . Briefly, stromal cell cultures maintained in vitamin and amino acid enriched McCoy's 5A medium, supplemented with 12.5% fetal bovine serum, 12.5% horse serum, 0.036% hydrocortisone, 1% PedStrep, were trypsinized and plated at low density (25-30,000 cell/ ml) in 2.5% methylcellulose supplemented with IL-la (25 U/mL) and TNFa (100 U/mL). After 2 weeks, colonies are plucked from the methylcellulose medium and added to liquid medium in the presence of basic-Fibroblast Growth Factor (b-FGF) (10 ng/mL) to re-establish adherent cell cultures. Only early passaged (four to ten passages) CDCL cells were used in the experiments described in this study. Experimental cultures were seeded at low density (1 x lo4 cells/mL) in six-well tissue culture plates (Costar, Cambridge, MA) or T-25 cm2 flasks (Corning, Corning, NY) and grown to visual confluence before initiation of experimental conditions.
Cytokines
Recombinant human IL-la, TNFa, GM-CSF, and erythropoietin were obtained from R & D Systems Logan, UT), 10-P M hydrocortisone (Sigma Chemicals, (Minneapolis, MN). Bladder carcinoma cell (5637) conditioned medium was a gift from Micheal Clarke (Department of Internal Medicine, University of MichiColony-stimulating factor measurements gan).
GM-CSF and G-CSF concentrations in experimental culture supernatants were determined by enzymelinked immunosorbent assay (ELISA) (R & D Systems, Minneapolis, MN). ELISA optical densities were measured and analyzed by an ELISA plate reader (Molecular Devices Corp., Menlo Park, CA) interfaced with a n IBM computer using the Softmax program (Molecular Devices Corp., Menlo Park, CA). The ranges of cytokine detection in the ELISA were 1.5-750 pg/mL (GM-CSF) and 7.2-5,OOO pg/mL (G-CSF).
Colony-stimulating activity bioassay
Conditioned media were assayed for production of colony-stimulating activity (CSA) by colony-forming assay. Ficoll-Hypaque isolated marrow mononuclear cells were plated in methylcellulose (Terry Fox Laboratories, Vancouver, B.C., Canada), supplemented with either recombinant erythropoietin (2 U/mL) and GM-CSF (20 ng/mL), conditioned medium from bladder carcinoma cells (56371, or 72 hr-conditioned medium from uninduced bone marrow stromal cell cultures.
RESULTS

IL-la and TNFa synergistically stimulate bone marrow stromal cells t o produce G-CSF and GM-CSF
To evaluate the effect of IL-la and TNFa on production of G-CSF and GM-CSF by human BMS cells, we stimulated confluent cultures of multiply passaged cells with either IL-la or TNFa alone, or both simultaneously. To determine optimal concentrations of IL-la and TNFa for stimulating G-CSF and GM-CSF production, BMS cultures were stimulated individually with either IL-la or TNFa at varying concentrations ( Fig.  1) . Although the relative levels of IL-la induced G-CSF and GM-CSF were significantly different, with G-CSF being higher, the optimal IL-la concentration for inducing both CSFs was the same (Fig. 1A) . TNFa was less effective than IL-la a t inducing G-CSF and GM-CSF production by BMS cultures. Unlike IL-la, however, TNFa was more effective in stimulating production of GM-CSF than G-CSF over the concentration range tested (Fig. 1B) .
When added together at an optimal concentration, IL-la (5-25 U/mL) and TNFa(50-100 U/mL) elicit secretion of both G-CSF and GM-CSF to levels significantly greater than either cytokine alone. In order to demonstrate synergy, the response to two agents must be greater than twice the response of each individual agent. Bone marrow stromal cell cultures stimulated individually with IL-la (25 U/mL) or TNFa (100 U/mL) released 1,800 pg/mL and <10 pg/ml of G-CSF into the culture supernatant, respectively. When stimulated with IL-la and TNF together, however, stromal cells released 5,225 pg/ml G-CSF into the culture supernatant ( Fig. 2A) . Similarly, GM-CSF production by stroma1 cells stimulated with IL-la and TNFa was only 27.5 pg/ml and <8 pg/ml, respectively. Stromal cell cul- tures that were simultaneously stimulated with IL-la and TNFa released 82.3 pg/ml GM-CSF into culture supernatants (Fig. 2B) , representing nearly a threefold increase in GM-CSF production compared to IL-la alone and greather than tenfold increase over TNFa alone. Therefore, IL-la is a much more potent inducer of myeloid-CSF production by BMS cells than TNFa, but co-stimulation with both cytokines results in synergistic production of G-CSF and GM-CSF.
IL-la and TNFa synergistically stimulate a marrow stroma-derived cell strain to produce G-CSF and GM-CSF We next asked if the synergistic interaction observed between IL-la and TNFa in stimulating whole, multiply passaged BMS cells to secrete myeloid-CSFs could be observed in a homogeneous, cytokine producing population of BMS cells. For these experiments we used a clonally derived human bone marrow stroma-derived cell strain (CDCL) (isolated as described in Materials and Methods). As previously described by Singer (19891, cell conditioned medium. Conditioned medium from CDCL cell cultures was just as effective as recombinant GM-CSF and erythropoietin in supporting hematopoietic progenitor cell proliferation in a colony-forming assay (Table I) . When stimulated with IL-la (25 UlmL) or TNFa (100 U/mL) individually, CDCL cells released significantly higher levels of G-CSF and GM-CSF into the culture supernatant than did the unfractionated stromal cell cultures. IL-la stimulated CDCL cells produced greater than 10.8 ng/ml G-CSF and 7.6 ng/ml GM-CSF (Fig. 3) , more than 10,000-fold and 69-fold greater production of G-CSF and GM-CSF, respectively, than unstimulated cultures. TNFa stimulated CDCL cultures released no detectable G-CSF into the culture medium. As with BMS cultures, TNFa was less effective than IL-la in stimulating GM-CSF production by CDCL cells. TNFa induced GM-CSF production by CDCL cells was 1,488 pg/ml. As with the unfractionated stromal cultures, a very large synergistic effect between IL-la and TNFa was observed in the CDCL cultures; cultures co-stimulated with both cytokines produced 46.5 ng/ml G-CSF and 25 ng/ml GM-CSF, respectively (Fig. 3) .
To determine if the difference in levels of IL-la and TNFa induced G-CSF and GM-CSF production by BMS and CDCL cells could be due to a difference in optimal IL-la and TNFa concentration, we next performed a dose-response analysis. Similar to the dose response results obtained with whole BMS cells, we found a significant difference in the relative magnitude of cytokine induced G-CSF and GM-CSF produced by the CDCL cultures. However, the optimal IL-la and TNFa concentrations for achieving maximal production of G-CSF and GM-CSF were the same as for the BMS cultures (Fig. 4) .
IL-la and TNFa mitogenic effect
We next asked whether the stimulatory effect of IL-la and TNFa on G-CSF and GM-CSF production could be explained, in part, by a significant expansion in cell number. There are several reports that show IL-1 and TNF can, under some conditions, induce some cell types (e.g., fibroblasts, smooth muscle cells, and macrophages) to undergo mitogenic proliferation (Branch et al., 1989; Sugarman et al., 1985; Dukovich et al., 1986; Vilcek et al., 1986; Schmidt et al., 1982; Dinarello, 1985; Kohase et al., 1986; Ikeda et al., 1990) . We found, however, that neighter IL-la or TNFa alone nor the two together resulted in a significant increase in cell number in either BMS cultures or CDCL cultures. After a 72-hr stimulation, under each condition, less than one culture doubling was observed (Table 11) . Therefore, it appears that the increased CSF production, in particular the synergistic stimulation of GMand G-CSF secretion, was the result of increased production on a per cell basis. Kinetics of myeloid-CSF production by a stromal-derived cell strain In the experiments described aboved, the production of myeloid-CSFs was determined via supernatant assays, obtained after 12 or 24 hr of stimulation. We next asked whether the apprent synergy between IL-la and TNFa reflected an acceleration in production kinetics. For this experiment we used confluent CDCL cultures stimulated as before, by removing small aliquots of supernatants at various times over a 72-hr period and determining the concentration of G-CSF. Not until about 6-8 hr of stimulation could we begin to detect an increase in G-CSF levels. Similarly, not until about 12 hr of stimulation could we begin to detect synergy between IL-la and TNFa. Interestingly, whereas the levels of the respective cytokine induced G-CSF were significantly different over the first 24 hr, the respective rates of production were very similar. Also, only the level of G-CSF in the IL-la + TNF stimulated cultures appeared to approach a plateau after 72 hr (Fig. 5) . Therefore, the observed synergy did not result in a significant acceleration in secretion kinetics for either IL-la or TNFa. DISCUSSION In this study, we demonstrate that ILa and TNFa act synergistically to stimulate human bone marrow stroma1 (BMS) cells to produce GM-CSF and G-CSF. We further demonstrate that IL-la and TNFa act synergistically to stimulate cultures of a human bone marrow stroma-derived cell strain (CDCL) to produce GM-CSF and G-CSF. Our data show that in both cultures, IL-la was a more potent inducer of cytokine secretion than TNFa, and cultures stimulated with IL-la alone secreted much higher levels of G-CSF into the culture supernatant than GM-CSF. TNFa, though less potent than IL-la, was more effective in stimulating production of GM-CSF than G-CSF. In some instances, TNFa failed to stimulate secretion of detectable levels of G-CSF into the culture supernatant. This may, in part, be due to variation between strornal cells from different bone marrow donors. However, in all cases co-stimulation with IL-la and TNFa caused secretion of G-CSF to levels significantly greater than those observed with IL-la alone.
Although the patterns of IL-la and TNFa induction of cytokine production were similar for the BMS and CDCL cultures, stimulated CDCL cultures secreted significantly higher levels of GM-and G-CSF into the culture supernatant than did stimulated BMS cultures. The respective IL-la and TNFa dose response curves for BMS and CDCL cultures were nearly identical, thus ruling out a difference in maximally stimulating concentrations of IL-la and TNFa as an explanation for the disparity in CSF production levels. Likewise, unstimulated CDCL cultures constitutively secreted detectable levels of GM-CSF into the culture supernatant and, on occasion, G-CSF, whereas unstimulated BMS cultures did not.
Mitogenic activity has been attributed to both IL-1 and TNF. However under the conditions used in this study, neither monokine caused a significant increase in cell number (Table 11 ), suggesting that the increase in cytokine production observed in the cultures was due to increased production per cell. These data demonstrate that mitogenic activity by IL-la and TNFa is not required for stimulation of myeloid-CSF production by human bone marrow stromal cells.
These data taken together suggest that a subset of bone marrow stromal cells, represented by CDCL cells, may be a major source of G-CSF and, to a lesser degree, GM-CSF in the marrow microenvironment. The proposition of marrow stromal cell heterogeneity is supported by a recent report by Ozawa et al. (1991) , who showed, using in situ hybridization, that a subpopulation of bone marrow stromal cells appears to be the main source of G-CSF. The present results should be considered in light of previous studies of the effects of IL-1 and TNF on diverse mesenchymal cell responses. To compliment their individual pleiotropic affects, IL-1 and TNF have been shown to interact with other cytokines, as well as with each other, in an additive and sometimes supra-additive manner (Branch et al., 1989; Seelentag et al., 1987; Nakagawa et al., 1989; Leizer et al., 1990; Elias et al., 1988; Wankowicz et al., 1988; Male and Pryce, 1988; Brach et al., 1992; Hoang et al., 1989; Chantry et al., 1989; Tanner et al., 1992; Stashenko et al., 1987; Mandrup-Poulsen et al., 1987; Brox-meyer et al., 1986) . In particular, Wankowicz et al. (1988) found that IL-1 and TNF synergistically stimulated leukocyte migration during inflammation and Stashenko et al. (1987) found that IL-la and TNFa stimulated bone resorption with apparently supra-additive kinetics. Similar to the IL-1/TNF synergy seen in the present study with bone marrow stromal cells, Leizer et al. (1990) reported finding synergy between IL-la/P and TNFa/P in stimulating production of GM-CSF and G-CSF by human synovial fibroblasts in vitro. Synergy between IL-1 and TNF has been observed in in vivo studies as well: Movat et al. (1987) observed that IL-la or p in combination with TNFa synergistically induced inflammation and microvascular injury in rabbits, and Okusawa et al. (1988) observed synergistic induction of a severe shock-like state in rabbits when injected with IL-1p and TNFa.
Within the hematopoietic system, there have been several reports of IL-1 and TNF inducing hematopoietic growth factor (HGF) production, especially GM-CSF, and in some cases, G-CSF (Hamilton et al., 1992; Akashi et al., 1989; Koeffler et al., 1987; Munker et al., 1986; Fibbe et al., 1988; Lee et al., 1987; Sieff et al., 1987 Sieff et al., ,1988 Kaushansky et al., 1988; Bagby et al., 1986; Broudy et al., 1986; Zucali et al., 1986; Zoellner et al., 1982) by mesenchymal cells such as fibroblasts, endothelial cells, and smooth muscle cells. To what extent IL-la and TNFa synergy occurs in vivo is not clear at this time. In contrast to the present study, Vogel et al. (1987) reported that simultaneous injection of optimal concentrations of recombinant IL-la and TNFa in mice stimulated only a n additive increase in colony-stimulating activity (CSA) over that observed with either cytokine alone. However, these previous studies were performed without the benefit of specific or quantitative ELISAs. One possible explanation for this apparent discrepancy is that the CSA assay is not sensitive enough to detect supra-additive levels of GM-and G-CSF production by marrow stromal cells. This might preclude the systemic observation of IL-1ITNF synergy. Taken together, these data provide further support for the importance of IL-1 and TNF in the regulation of bone marrow hematopoiesis via stimulation of marrow stromal cells.
IL-1 and TNF have been shown to be intermediates of inflammation during an immune response. The relative potency of IL-1 and TNF to induce production of GM-or G-CSF, in conjunction with their synergistic effect, suggests optional pathways for the induction of myeloid-CSFs in the marrow microenvironment. One option is to have induction by IL-1 alone. This results in a significant increase in both GM-and G-CSF, with the increase being greater for G-CSF. An alternative path has stimulation with TNF alone. This option results in an increase in GM-CSF but not G-CSF. A third option would have stimulation by both monokines, which causes a synergistic increase of both GM-and G-CSF. The unique activities of GM-and G-CSF have been well documented. GM-CSF has been shown to inhibit neutrophil migration as well as to activate mature neutrophils (Gasson et al., 1984; Vadas et al., 19831, eosinophils (Vadas et al., 1983a,b) , and monocytes (Grabstein et al., 1986) . G-CSF has been found to activate neutrophi1 toxicity (Lopez et al., 1983) . Whether or not the response is primarily localized to the marrow or is systemic may determine which pathway is activated.
A recent report of synergistic interactions between cytokines and HGFs has focused more attention on synergy as a mechanism to greatly expand the biological repertoir of individual regulators of hematopoiesis (Jacobsen et al., 1992) . At this time, however, little is known about the molecular basis for these synergistic interactions. Current experiments are underway to determine the molecular basis for the synergy between IL-la and TNFa described here, including the possibility of receptor induction, cooperative post-receptor signal transduction, and cooperative promoter binding by trans-acting factors. 
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